rozlytrek
roche registration gmbh - entrectinib - cancer; carcinoma, non-small-cell lung - Æxlishemjandi lyf - rozlytrek as monotherapy is indicated for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (ntrk) gene fusion,who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, andwho have not received a prior ntrk inhibitorwho have no satisfactory treatment options. rozlytrek as monotherapy is indicated for the treatment of adult patients with ros1 positive, advanced non small cell lung cancer (nsclc) not previously treated with ros1 inhibitors.
amoxicillin mylan (amoxicillin mylan) tafla 750 mg
viatris limited - amoxicillinum tríhýdrat - tafla - 750 mg
amoxicillin mylan (amoxicillin mylan) hart hylki 500 mg
viatris limited - amoxicillinum tríhýdrat - hart hylki - 500 mg
prasugrel krka filmuhúðuð tafla 10 mg
krka, d.d., novo mesto - prasugrelum inn - filmuhúðuð tafla - 10 mg
amoxin mixtúruduft, dreifa 100 mg/ml
ratiopharm gmbh* - amoxicillinum tríhýdrat - mixtúruduft, dreifa - 100 mg/ml
omeprazol actavis magasýruþolið hart hylki 40 mg
actavis group ptc ehf. - omeprazolum inn - magasýruþolið hart hylki - 40 mg
omeprazol actavis magasýruþolið hart hylki 20 mg
actavis group ptc ehf. - omeprazolum inn - magasýruþolið hart hylki - 20 mg
omeprazol actavis magasýruþolið hart hylki 10 mg
actavis group ptc ehf. - omeprazolum inn - magasýruþolið hart hylki - 10 mg
amoxin filmuhúðuð tafla 500 mg
ratiopharm gmbh* - amoxicillinum tríhýdrat - filmuhúðuð tafla - 500 mg
esomeprazol actavis magasýruþolin tafla 40 mg
actavis group ptc ehf. - esomeprazolum magnesíum - magasýruþolin tafla - 40 mg